MONNIEQUE SINGLETON: Open Payments
NPI 1336193713 · ORANGEBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,448 in 67 payments from 21 companies in 2025. Trend: 2023 $1,759 · 2024 $1,514 · 2025 $1,448
Food & beverage: $1,448
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $355 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $186 |
| Corcept Therapeutics | 7 | $156 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $146 |
| Merck Sharp & Dohme LLC | 5 | $98 |
| CorVista Health, Inc. | 2 | $82 |
| Amgen Inc. | 4 | $65 |
| Abbott Laboratories | 3 | $56 |
| Novo Nordisk Inc | 2 | $43 |
| Ardelyx, Inc. | 1 | $32 |
Products named: Kerendia, BREZTRI, Korlym, JARDIANCE, FARXIGA, VERQUVO, CorVista System, AIRSUPRA.
Industry payments across SC — which companies pay providers there.
